179 related articles for article (PubMed ID: 21894103)
1. POMHS 9b - antipsychotic prescribing in people with a learning disability.
Thalitaya MD; Udu V; Nicholls M; Clark T; Prasher VP
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S50-6. PubMed ID: 21894103
[TBL] [Abstract][Full Text] [Related]
2. Improving prescribing practice in psychiatry: the experience of the Prescribing Observatory for Mental Health (POMH-UK).
Barnes TR; Paton C
Int Rev Psychiatry; 2011 Aug; 23(4):328-35. PubMed ID: 22026488
[TBL] [Abstract][Full Text] [Related]
3. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
Paton C; Bhatti S; Purandare K; Roy A; Barnes T
BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic prescribing in nursing homes: an audit report.
Morrison A
Qual Prim Care; 2009; 17(5):359-62. PubMed ID: 20003722
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services.
Barnes TR; Banerjee S; Collins N; Treloar A; McIntyre SM; Paton C
Br J Psychiatry; 2012 Sep; 201(3):221-6. PubMed ID: 22790679
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic long-acting injections: prescribing practice in the UK.
Barnes TR; Shingleton-Smith A; Paton C
Br J Psychiatry Suppl; 2009 Nov; 52():S37-42. PubMed ID: 19880915
[TBL] [Abstract][Full Text] [Related]
8. Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK.
Barnes TR; Bhatti SF; Adroer R; Paton C
BMJ Open; 2015 Oct; 5(10):e007633. PubMed ID: 26428329
[TBL] [Abstract][Full Text] [Related]
9. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
[TBL] [Abstract][Full Text] [Related]
10. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
Wightman R; Fielding J; Green S
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
[TBL] [Abstract][Full Text] [Related]
11. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
[TBL] [Abstract][Full Text] [Related]
12. Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales.
Patel MX; Bishara D; Jayakumar S; Zalewska K; Shiers D; Crawford MJ; Cooper SJ
Eur Neuropsychopharmacol; 2014 Apr; 24(4):499-509. PubMed ID: 24491953
[TBL] [Abstract][Full Text] [Related]
13. Role of the prescribing observatory for mental health.
Barnes TR; Paton C
Br J Psychiatry; 2012 Dec; 201(6):428-9. PubMed ID: 23209087
[TBL] [Abstract][Full Text] [Related]
14. High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing.
Paton C; Barnes TR; Cavanagh MR; Taylor D; Lelliott P;
Br J Psychiatry; 2008 Jun; 192(6):435-9. PubMed ID: 18515893
[TBL] [Abstract][Full Text] [Related]
15. Survey of depot antipsychotic prescribing in southern Adelaide.
Herriot P; Kheirani K
Australas Psychiatry; 2005 Sep; 13(3):253-7. PubMed ID: 16174198
[TBL] [Abstract][Full Text] [Related]
16. Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study.
Ashcroft DM; Frischer M; Lockett J; Chapman SR
Pharmacoepidemiol Drug Saf; 2002 Jun; 11(4):285-9. PubMed ID: 12138596
[TBL] [Abstract][Full Text] [Related]
17. Clinicians' reasons for antipsychotic coprescribing.
Sernyak MJ; Rosenheck R
J Clin Psychiatry; 2004 Dec; 65(12):1597-600. PubMed ID: 15641863
[TBL] [Abstract][Full Text] [Related]
18. Explicit review of risperidone long-acting injection prescribing practice.
Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
[TBL] [Abstract][Full Text] [Related]
19. The pharmacological management of acute behavioural disturbance: Data from a clinical audit conducted in UK mental health services.
Paton C; Adams CE; Dye S; Fagan E; Okocha C; Barnes TR
J Psychopharmacol; 2019 Apr; 33(4):472-481. PubMed ID: 30565486
[TBL] [Abstract][Full Text] [Related]
20. Explicit versus implicit review to explore combination antipsychotic prescribing.
Wheeler A
J Eval Clin Pract; 2009 Aug; 15(4):685-91. PubMed ID: 19674220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
